Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Raloxifene vs Strontium Ranelate in Postmenopausal Osteoporosis
NCT01544894Phase 4Completed
- Sponsor
- UVEG
- Start
- Sep 2009
- Primary completion
- Oct 2011
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of raloxifene, strontium ranelate in postmenopausal osteoporosis, sponsored by UVEG. Started Sep 2009; status: completed.
02
Drugs
raloxifenestrontium ranelate
03
Conditions
postmenopausal osteoporosis
Beyond the preview
Go deeper on NCT01544894.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01544894.